Drug Profile
HIV delta 4 vaccine
Latest Information Update: 13 Jul 2001
Price :
$50
*
At a glance
- Originator New England Regional Primate Center
- Developer International Association of Physicians in Aids Care; New England Regional Primate Center
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 13 Jul 2001 Discontinued-Preclinical for HIV-1 infections in USA (Unknown route)
- 13 Mar 1998 New profile
- 13 Mar 1998 Preclinical development for HIV-1 infections in USA (Unknown route)